These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16120231)

  • 1. Correlation of non-invasive urodynamics with international prostate symptom score and prostate volume.
    Appell RA
    Curr Urol Rep; 2005 Sep; 6(5):325. PubMed ID: 16120231
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation of transrectal ultrasonographic findings of the prostate with the occurrence of detrusor instability in patients with benign prostatic hyperplasia.
    Tong YC; Lin YM; Yang WH; Tzai TS; Lin JS
    Urol Int; 1995; 55(3):154-7. PubMed ID: 8540161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate volume did not affect voiding function improvements in diode laser enucleation of the prostate.
    Yang SS; Hsieh CH; Chiang IN; Lin CD; Chang SJ
    J Urol; 2013 Mar; 189(3):993-8. PubMed ID: 23017511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial: cause and effect of lower urinary tract symptoms.
    Blaivas JG
    J Urol; 2002 Oct; 168(4 Pt 1):1464. PubMed ID: 12352418
    [No Abstract]   [Full Text] [Related]  

  • 5. Preliminary results of power Doppler imaging in benign prostatic hyperplasia.
    Kojima M; Watanabe H; Watanabe M; Okihara K; Naya Y; Ukimura O
    Ultrasound Med Biol; 1997; 23(9):1305-9. PubMed ID: 9428128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doppler resistive index in benign prostatic hyperplasia: correlation with ultrasonic appearance of the prostate and infravesical obstruction.
    Kojima M; Ochiai A; Naya Y; Okihara K; Ukimura O; Miki T
    Eur Urol; 2000 Apr; 37(4):436-42. PubMed ID: 10765074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower urinary tract symptoms, prostate volume and uroflow in norwegian community men.
    Overland GB; Vatten L; Rhodes T; DeMuro C; Jacobsen G; Vada K; Angelsen A; Girman CJ
    Eur Urol; 2001 Jan; 39(1):36-41. PubMed ID: 11173937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of transrectal ultrasound measurements of prostate and transition zone size with symptom score, bother score, urinary flow rate, and post-void residual volume.
    Terris MK; Afzal N; Kabalin JN
    Urology; 1998 Sep; 52(3):462-6. PubMed ID: 9730461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urodynamic study in patients with prostatic hyperplasia].
    Shishido K; Yamaguchi O
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():346-51. PubMed ID: 12599598
    [No Abstract]   [Full Text] [Related]  

  • 10. Symptoms, prostate volume, and urodynamic findings in elderly male volunteers without and with LUTS and in patients with LUTS suggestive of benign prostatic hyperplasia.
    Eckhardt MD; van Venrooij GE; Boon TA
    Urology; 2001 Dec; 58(6):966-71. PubMed ID: 11744470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostatic central zone volume, lower urinary tract symptom severity and peak urinary flow rates in community dwelling men.
    Corica FA; Jacobsen SJ; King BF; Bostwick DG; Jacobson DJ; Girman CJ; Lieber MM
    J Urol; 1999 Mar; 161(3):831-4. PubMed ID: 10022695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in parameters before and after alpha-1-blocker therapy for men with lower urinary tract symptoms using color doppler ultrasound urodynamics: possible application for prediction of clinical outcome.
    Watanabe Y; Yokoyama T; Ozawa H; Nishiguchi J; Nose H; Kumon H
    Urol Int; 2004; 73(3):252-7. PubMed ID: 15539846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical diagnosis of benign prostatic hyperplasia].
    Homma Y
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():327-32. PubMed ID: 12599594
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparation of the predictive value between ultrasonography and urodynamics for the efficacy of transurethral resection of prostate in benign prostatic hyperplasia patients.
    Qi J; Yu YJ; Huang T; Xu D; Jiao Y; Kang J; Chen YQ; Zhu YK; Huang YR
    Chin Med J (Engl); 2012 May; 125(9):1536-41. PubMed ID: 22800817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus conference about imaging of Benign Prostatic Hypertrophy.
    Gozzi G; Conti G; Peroni R; Spatafora S; Pavlica P; Cammarota T; Bertolotto M
    Radiol Med; 2005 Sep; 110(3):179-89. PubMed ID: 16200040
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation between uroflowmetry, prostate volume, postvoid residue, and lower urinary tract symptoms as measured by the International Prostate Symptom Score.
    Ezz el Din K; Kiemeney LA; de Wildt MJ; Debruyne FM; de la Rosette JJ
    Urology; 1996 Sep; 48(3):393-7. PubMed ID: 8804492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endourological treatment of benign prostatic hypertrophy. Preliminary report].
    Rodríquez Duarte C
    Arch Esp Urol; 1991 Apr; 44(3):283-5. PubMed ID: 1714266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
    Roehrborn CG; McVary KT; Elion-Mboussa A; Viktrup L
    J Urol; 2008 Oct; 180(4):1228-34. PubMed ID: 18722631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of saw palmetto soft gel capsule on lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized trial in Shanghai, China.
    Shi R; Xie Q; Gang X; Lun J; Cheng L; Pantuck A; Rao J
    J Urol; 2008 Feb; 179(2):610-5. PubMed ID: 18082217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Data from frequency-volume charts versus symptom scores and quality of life score in men with lower urinary tract symptoms due to benign prostatic hyperplasia.
    van Venrooij GE; Eckhardt MD; Gisolf KW; Boon TA
    Eur Urol; 2001 Jan; 39(1):42-7. PubMed ID: 11173938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.